Search
Back

Zanubrutinib

CAS 1691249-45-2
Zanubrutinib

General Information

Zanubrutinib is a small molecule inhibitor of Bruton tyrosine kinase, with more selectivity compared with approved agents in its class, like ibrutinib.


About the API

Technology Synthetic
Therapeutic category Oncology
Systematic Name (7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Available formulations Oral Solid Long-Acting
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.